Igor Bilinsky

Affiliations

  • Chief Operating Officer at Iovance Biotherapeutics Inc. (IOVA), 2025-06-04
  • Chief Business Officer at Oncternal Therapeutics Inc. (ONCT), 2021-02-16
  • Chief Operating Officer at Ampliphi Biosciences Corp (APHB), 2017-06-01
  • Gm, Immuno-Oncology/Svp Sp Ops at Ignyta Inc. (RXDX), 2016-01-11
  • Sr Vp, Corporate Development at Vical Inc (VICL), 2015-07-15
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
VICL $1.42 90,000 $127,800.00 145,692 2014-01-10 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
VICL $0.70 1,258 $878.71 193,798 2015-07-13 Filing
VICL $0.93 1,257 $1,172.78 195,056 2015-04-13 Filing
VICL $1.16 1,335 $1,543.66 126,313 2015-01-12 Filing
VICL $1.08 1,335 $1,445.54 127,648 2014-10-13 Filing
VICL $1.25 12,500 $15,671.25 128,983 2014-08-26 Filing